Cargando…

Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis

Neurodegenerative process in amyotrophic lateral sclerosis (ALS) has been proven to involve several cortical and subcortical brain regions within and beyond motor areas. However, how ALS pathology spreads progressively during disease evolution is still unknown. In this cross-sectional study we inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Trojsi, Francesca, Caiazzo, Giuseppina, Corbo, Daniele, Piccirillo, Giovanni, Cristillo, Viviana, Femiano, Cinzia, Ferrantino, Teresa, Cirillo, Mario, Monsurrò, Maria Rosaria, Esposito, Fabrizio, Tedeschi, Gioacchino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368555/
https://www.ncbi.nlm.nih.gov/pubmed/25793718
http://dx.doi.org/10.1371/journal.pone.0119045
_version_ 1782362639127543808
author Trojsi, Francesca
Caiazzo, Giuseppina
Corbo, Daniele
Piccirillo, Giovanni
Cristillo, Viviana
Femiano, Cinzia
Ferrantino, Teresa
Cirillo, Mario
Monsurrò, Maria Rosaria
Esposito, Fabrizio
Tedeschi, Gioacchino
author_facet Trojsi, Francesca
Caiazzo, Giuseppina
Corbo, Daniele
Piccirillo, Giovanni
Cristillo, Viviana
Femiano, Cinzia
Ferrantino, Teresa
Cirillo, Mario
Monsurrò, Maria Rosaria
Esposito, Fabrizio
Tedeschi, Gioacchino
author_sort Trojsi, Francesca
collection PubMed
description Neurodegenerative process in amyotrophic lateral sclerosis (ALS) has been proven to involve several cortical and subcortical brain regions within and beyond motor areas. However, how ALS pathology spreads progressively during disease evolution is still unknown. In this cross-sectional study we investigated 54 ALS patients, divided into 3 subsets according to the clinical stage, and 18 age and sex-matched healthy controls, by using tract-based spatial statistics (TBSS) diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) analyses. We aimed to identify white (WM) and gray matter (GM) patterns of disease distinctive of each clinical stage, corresponding to specific clinical milestones. ALS cases in stage 2A (i.e., at diagnosis) were characterized by GM and WM impairment of left motor and premotor cortices and brainstem at ponto-mesenchephalic junction. ALS patients in clinical stage 2B (with impairment of two functional regions) exhibited decreased fractional anisotropy (FA) (p<0.001, uncorrected) and increased mean (MD) and radial diffusivity (RD) (p<0.001, uncorrected) in the left cerebellar hemisphere and brainstem precerebellar nuclei, as well as in motor areas, while GM atrophy (p<0.001, uncorrected) was detected only in the left inferior frontal gyrus and right cuneus. Finally, ALS patients in stage 3 (with impairment of three functional regions) exhibited decreased FA and increased MD and RD (p<0.05, corrected) within WM underneath bilateral pre and postcentral gyri, corpus callosum midbody, long associative tracts and midbrain, while no significant clusters of GM atrophy were observed. Our findings reinforce the hypothesis that the neurodegenerative process propagates along the axonal pathways and develops beyond motor areas from early stages, involving progressively several frontotemporal regions and their afferents and efferents, while the detection of GM atrophy in earlier stages and its disappearance in later stages may be the result of reactive gliosis.
format Online
Article
Text
id pubmed-4368555
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43685552015-03-27 Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis Trojsi, Francesca Caiazzo, Giuseppina Corbo, Daniele Piccirillo, Giovanni Cristillo, Viviana Femiano, Cinzia Ferrantino, Teresa Cirillo, Mario Monsurrò, Maria Rosaria Esposito, Fabrizio Tedeschi, Gioacchino PLoS One Research Article Neurodegenerative process in amyotrophic lateral sclerosis (ALS) has been proven to involve several cortical and subcortical brain regions within and beyond motor areas. However, how ALS pathology spreads progressively during disease evolution is still unknown. In this cross-sectional study we investigated 54 ALS patients, divided into 3 subsets according to the clinical stage, and 18 age and sex-matched healthy controls, by using tract-based spatial statistics (TBSS) diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) analyses. We aimed to identify white (WM) and gray matter (GM) patterns of disease distinctive of each clinical stage, corresponding to specific clinical milestones. ALS cases in stage 2A (i.e., at diagnosis) were characterized by GM and WM impairment of left motor and premotor cortices and brainstem at ponto-mesenchephalic junction. ALS patients in clinical stage 2B (with impairment of two functional regions) exhibited decreased fractional anisotropy (FA) (p<0.001, uncorrected) and increased mean (MD) and radial diffusivity (RD) (p<0.001, uncorrected) in the left cerebellar hemisphere and brainstem precerebellar nuclei, as well as in motor areas, while GM atrophy (p<0.001, uncorrected) was detected only in the left inferior frontal gyrus and right cuneus. Finally, ALS patients in stage 3 (with impairment of three functional regions) exhibited decreased FA and increased MD and RD (p<0.05, corrected) within WM underneath bilateral pre and postcentral gyri, corpus callosum midbody, long associative tracts and midbrain, while no significant clusters of GM atrophy were observed. Our findings reinforce the hypothesis that the neurodegenerative process propagates along the axonal pathways and develops beyond motor areas from early stages, involving progressively several frontotemporal regions and their afferents and efferents, while the detection of GM atrophy in earlier stages and its disappearance in later stages may be the result of reactive gliosis. Public Library of Science 2015-03-20 /pmc/articles/PMC4368555/ /pubmed/25793718 http://dx.doi.org/10.1371/journal.pone.0119045 Text en © 2015 Trojsi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Trojsi, Francesca
Caiazzo, Giuseppina
Corbo, Daniele
Piccirillo, Giovanni
Cristillo, Viviana
Femiano, Cinzia
Ferrantino, Teresa
Cirillo, Mario
Monsurrò, Maria Rosaria
Esposito, Fabrizio
Tedeschi, Gioacchino
Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis
title Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis
title_full Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis
title_fullStr Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis
title_full_unstemmed Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis
title_short Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis
title_sort microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368555/
https://www.ncbi.nlm.nih.gov/pubmed/25793718
http://dx.doi.org/10.1371/journal.pone.0119045
work_keys_str_mv AT trojsifrancesca microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis
AT caiazzogiuseppina microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis
AT corbodaniele microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis
AT piccirillogiovanni microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis
AT cristilloviviana microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis
AT femianocinzia microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis
AT ferrantinoteresa microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis
AT cirillomario microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis
AT monsurromariarosaria microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis
AT espositofabrizio microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis
AT tedeschigioacchino microstructuralchangesacrossdifferentclinicalmilestonesofdiseaseinamyotrophiclateralsclerosis